循环vaspin水平与妊娠糖尿病的关联:系统综述与Meta分析

龙斯思; 马淑娟; 张佳月; 郭楚豪; 谭红专

doi:10.16462/j.cnki.zhjbkz.2020.03.020

循环vaspin水平与妊娠糖尿病的关联:系统综述与Meta分析

doi: 10.16462/j.cnki.zhjbkz.2020.03.020

410008 长沙, 中南大学湘雅公共卫生学院

基金项目: 国家自然科学基金(81773535);湖南省重点研发计划项目(2018SK2061)

详细信息

通讯作者:
谭红专, E-mail:tanhz99@qq.com

中图分类号: R587.1;R181
计量
- 文章访问数: 356
- HTML全文浏览量: 224
- PDF下载量: 25
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-29
- 修回日期: 2020-01-21
- 刊出日期: 2020-03-10

Association between circulating vaspin levels and the risk of gestational diabetes mellitus:A systematic review and Meta-analysis

Xiangya School of Public Health, Central South University, Changsha 410008, China

Funds: National Natural Science Foundation of China(81773535); Key Research and Development Program of Hunan Province(2018SK2061)

More Information

Corresponding author: TAN Hong-zhuan, E-mail:tanhz99@qq.com

摘要

摘要: 目的评价循环vaspin水平与妊娠糖尿病(gestational diabetes mellitus, GDM)的关联。方法系统检索PubMed、EMBASE、Web of Science、中国知网和万方数据库。检索时间截至2019年6月。使用随机效应模型或固定效应模型, 计算合并标准化均数差(standardized mean differences, SMD)及其95%置信区间(confidence interval, CI)。通过亚组分析、Meta回归分析、敏感性分析和发表偏倚分析评价结果的异质性与稳定性。所有统计分析均使用STATA 12.0软件。结果共纳入2013年至2019年期间发表的9篇文献(11个研究), 涵盖738例GDM患者和661例健康孕妇。GDM患者和健康孕妇之间总体循环vaspin水平差异有统计学意义(SMD=0.613, 95% CI:0.044~1.182, P=0.035)。根据vaspin水平所处的孕期和体重指数(body mass index, BMI)是否匹配进行亚组分析, 其相关方向与总结果相似; 按照种族进行亚组分析, 发现在“欧洲人”亚组中vaspin水平与GDM可能无关; 通过敏感性分析, 在排除了质量中等的研究和BMI没有匹配的研究后, 循环vaspin水平与GDM的关系依然存在。结论在亚洲人群中, 孕产妇循环vaspin水平可能与GDM的风险呈正相关。
- vaspin水平 /
- 妊娠糖尿病 /
- BMI /
- 系统综述 /
- Meta分析
Abstract: Objective To review the existing literature and quantitatively evaluate the association of circulating vaspin levels and the risk of gestational diabetes mellitus(GDM). Methods We systematically searched the PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure, and WanfangData databases up to June 2019. Pooled standardized mean differences(SMDs) with 95% confidence intervals(CIs) were calculated using random-or fixed-effects models based on the heterogeneity of studies. Subgroup analyses, Meta-regression, sensitivity and publication bias were assessed to analyze the heterogeneity and the robustness of the results. All statistical analyses were performed using STATA 12.0. Results Nine articles(11 comparisons) published from 2013 to 2019 were included in our final Meta-analysis, covering a total of 738 patients with GDM and 661 normal pregnant women. There was significant difference in the overall maternal circulating vaspin levels between GDM patients and healthy pregnant women(SMD=0.613, 95% CI: 0.044-1.182, P=0.035). Subgroup analyses stratified by trimester in which vaspin was measured and whether BMI was matched suggested the similar trend to the overall result. Subgroup analysis according to ethnicity found that circulating vaspin level might not be related to GDM in "European" subgroup; sensitivity analysis by excluding moderate-quality studies and BMI-unmatched studies found that circulating vaspin levels were still related to GDM risk. Conclusions Our Meta-analysis indicated that maternal circulating vaspin levels might be positively correlated with the risk of GDM in Asians.
- Vaspin level /
- Gestational diabetes mellitus /
- Body mass index /
- Systematic review /
- Meta-analysis

HTML全文

图 1 文献筛选流程

Figure 1. PRISMA flow diagram of the study selection process.

下载: 全尺寸图片幻灯片

图 2 使用随机模型对循环vaspin和GDM关联的Meta分析

Figure 2. Meta-analysis of the association between circulating vaspin and gestational diabetes mellitus using random-effects model

下载: 全尺寸图片幻灯片

图 3 Begg漏斗图, 评估发表偏倚

Figure 3. Begg's funnel plot for the assessment of publication bias

下载: 全尺寸图片幻灯片

表 1 纳入研究的基本特征

Table 1. Main characteristics of all selected studies

纳入研究	时间	地区	研究设计类型	样本量GDM/C	GDM诊断标准	Vaspin测量所处孕期	BMI匹配情况	NOS评分	Vaspin水平(x±s, ng/ml)
纳入研究	时间	地区	研究设计类型	样本量GDM/C	GDM诊断标准	Vaspin测量所处孕期	BMI匹配情况	NOS评分	GDM组	对照组	P值
Gkiomisi^[21]	2013	希腊	病例对照	44/44	IADPSG	孕中期	匹配	6	0.088±0.048	0.0837±0.05	> 0.05
Gkiomisi^[21]	2013	希腊	病例对照	44/44	IADPSG	孕晚期	匹配	6	0.0704±0.039	0.0616±0.024	> 0.05
Gkiomisi^[21]	2013	希腊	病例对照	44/44	IADPSG	分娩后	匹配	6	0.0441±0.011	0.0401±0.012	> 0.05
Mm^[11]	2014	中国	病例对照	37/36	IADPSG	孕晚期	匹配	7	2.67±1.99	1.47±0.65	0.001
Jia^[12]	2015	中国	病例对照	84/92	HAPO	孕中期	不匹配^a	7	2.72±2.2	1.84±1.57	< 0.05
袁涛^[18]	2015	中国	病例对照	25/24	ADA	孕中期	匹配	7	22.36 ±7.27	22.63±9.11	0.867
王锐^[13]	2015	中国	病例对照	142/102	ADA	孕中期	不匹配^a	6	2.74±1.8	1.82±1.33	< 0.001
Tang^[20]	2017	中国	病例对照	37/37	IADPSG	孕晚期	不匹配^a	6	5.96±1.02	5.13±1.17	0.007
张丽萍^[22]	2018	中国	病例对照	98/124	Unclear	孕中期	不清楚	5	33.21±4.52	20.34±3.48	< 0.05
龚淼^[19]	2018	中国	病例对照	30/30	IADPSG	孕中期	匹配	7	0.77±0.39	0.50±0.32	0.005
Mierzynski^[8]	2019	波兰	病例对照	153/84	WHO	孕中期	不匹配^a	6	1.31±0.78	1.69±0.68	< 0.001
注:^a表示GDM病例组BMI水平高于对照组BMI水平。缩写:IADPSG:International Association of Diabetes and Pregnancy Study Groups，国际糖尿病和妊娠研究协会; ADA:American Diabetes Association，美国糖尿病协会; HAPO:Hyperglycemia and Adverse Pregnancy Outcome study，高血糖和不良妊娠结局研究

下载: 导出CSV

参考文献(23)

[1]	American Diabetes A. Gestational diabetes mellitus[J]. Diabetes care, 2004, 27 Suppl 1: S88-90. DOI: 10.2337/diacare.27.2007.s88.
[2]	Zhu Y, Zhang C. Prevalence of Gestational diabetes and risk of progression to type 2 diabetes: a global perspective[J]. CurrDiab Rep, 2016, 16(1): 7. DOI: 10.1007/s11892-015-0699-x.
[3]	Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes[J]. N Engl J Med, 2008, 358(19): 1991-2002. DOI: 10.1056/NEJMoa0707943.
[4]	Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and Meta-analysis[J]. Lancet, 2009, 373(9677): 1773-1779. DOI: 10.1016/S0140-6736(09)60731-5.
[5]	Li J, Song C, Li C, et al. Increased risk of cardiovascular disease in women with prior gestational diabetes: A systematic review and Meta-analysis[J]. Diabetes ResClin Pract, 2018, 140: 324-338. DOI: 10.1016/j.diabres.2018.03.054.
[6]	Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity[J]. Proc Natl Acad Sci U S A, 2005, 102(30): 10610-10615. DOI: 10.1073/pnas.0504703102.
[7]	Youn BS, Kloting N, Kratzsch J, et al. Serum vaspin concentrations in human obesity and type 2 diabetes[J]. Diabetes, 2008, 57(2): 372-377. DOI: 10.2337/db07-1045.
[8]	Mierzynsk IR, Poniedzialek-Czajkowska E, Dluski D, et al. Nesfatin-1 and Vaspin as Potential Novel Biomarkers for the Prediction and Early Diagnosis of Gestational Diabetes Mellitus[J]. Int J Mol Sci, 2019, 20(1): E159. DOI: 10.3390/ijms20010159.
[9]	Huo Y, Liu SX, Song GY, et al. Plasma levels and placental expression of vaspin in pregnant women with diabetes mellitus[J]. Braz J Med Bio Res, 2015, 48(3): 273-279. DOI: 10.1590/1414-431X20143432.
[10]	Teshigawara S, Wada J, Hida K, et al. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population[J]. J Clin Endocrinol metab, 2012, 97(7): E1202-1207. DOI: 10.1210/jc.2011-3297.
[11]	Mm WQ, Fan JX, Khor S, et al. Serum vaspin levels and vaspin mRNA expression in subcutaneous adipose tissue in women with gestational diabetes mellitus[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 182: 98-101. DOI: 10.1016/j.ejogrb.2014.09.008.
[12]	Jia X, Wang S, Ma N, et al. Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women[J]. Endocrine, 2015, 48(2): 533-540. DOI: 10.1007/s12020-014-0318-7.
[13]	王锐, 陆强, 王术艺, 等.血清25羟维生素D及vaspin水平与妊娠糖尿病关系的研究[J].国际内分泌代谢杂志, 2015, 5(35): 306-308. DOI: 10.3760/cma.j.issn.1673-4157.2015.05.005. Wang R, Lu Q, Wang SY, et al.Relationship between serum 25 hydroxy vitamin D, vaspin and gestafional diabetes mellitu[J]. Int J Endocrinol metab, 2015, 5(35):306-308. DOI: 10.3760/cma.j.issn.1673-4157.2015.05.005
[14]	张天嵩.实用循证医学方法学[M].第2版.长沙: 中南大学出版社, 2011. Zhang TS. Applied methodology for evidence-based medicine.[M]. 2rd ed. Changsha: Central South University Press, 2011.
[15]	Van Dijk GM, Maneva M, ColpaniV, et al. The association between vasomotor symptoms and metabolic health in peri-and postmenopausal women: a systematic review[J]. Maturitas, 2015, 80(2): 140-147. DOI: 10.1016/j.maturitas.2014.11.016.
[16]	Whitehead A, Whitehead J. A general parametric approach to the Meta-analysis of randomized clinical trials[J]. Stat Med, 1991, 10(11): 1665-1677. doi: 10.1002/sim.4780101105
[17]	Melsen WG, Bootsma MC, Rovers MM, et al. The effects of clinical and statistical heterogeneity on the predictive values of results from Meta-analyses[J]. Clin Microbiol Infect, 2014, 20(2): 123-129. DOI: 10.1111/1469-0691.12494.
[18]	袁涛, 王相清, 赵维纲, 等.不同糖耐量状态孕妇血清脂肪因子水平[J].中国临床营养杂志, 2015, 23(4): 203-208. doi: 10.3760/cma.j.issn.1674-635X.2015.04.002 Yuan T, Wang XQ, Zhao WG, et al. Serum adipocytokines in pregnant women with different glucose metabolism status [J]. Chin J Clin Nutr, 2015, 23(4):203-208. DOI: 10.3760/cma.j.issn.1674-635X.2015.04.002.
[19]	龚淼. OGTT对GDM孕妇血清vaspin水平的影响[D].唐山: 华北理工大学, 2018. Gong M. Changes in serum vaspin levels after Oral Glucose Tolerance Test in women withgestational diabetes mellitus[D]. Tangshan: North China University of Science and Technology, 2018.
[20]	Tang Y, Qiao P, Qu X, et al. Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes[J]. Clin Endocrinol(Oxf), 2017, 87(4): 344-349. DOI: 10.1111/cen.13403.
[21]	Gkiomisi A, Makedou KG, Anastasilakis AD, et al. Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum[J]. Cytokine, 2013, 61(1): 127-132. DOI: 10.1016/j.cyto.2012.09.006.
[22]	张丽萍.妊娠期糖尿病患者胎盘中炎症介质表达量与母体胰岛素抵抗、脂代谢的相关性研究[J].中国妇幼保健, 2018, 16(33): 3635-3638. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgfybj201816011 Zhang LP. Relationship between inflammatory mediator expression and maternal insulin resistance and lipid metabolism in placenta of patients with gestational diabetes mellitus[J]. Maternal and Child Health Care of China, 2018, 16(33): 3635-3638. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgfybj201816011
[23]	Suleymanoglu S, Tascilar E, Pirgon O, et al. Vaspin and its correlation with insulin sensitivity indices in obese children[J]. Diabetes Res Clin Pract, 2009, 84(3): 325-328. DOI: 10.1016/j.diabres.2009.03.008.